HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1)

被引:38
作者
Lata, Sneh [1 ,2 ]
Ali, Amjad [3 ]
Sood, Vikas [1 ,2 ,3 ]
Raja, Rameez [3 ]
Banerjea, Akhil C. [3 ]
机构
[1] Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India
[2] Guru Teg Bahadur Hosp, Delhi 110095, India
[3] Natl Inst Immunol, Virol Lab, New Delhi 110067, India
来源
NATURE COMMUNICATIONS | 2015年 / 6卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE; PROTEASOMAL DEGRADATION; PROTEIN-DEGRADATION; 20S PROTEASOMES; NUCLEAR EXPORT; UBIQUITIN; TRANSACTIVATOR; INHIBITION; APOPTOSIS;
D O I
10.1038/ncomms8244
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 gene expression and replication largely depend on the regulatory proteins Tat and Rev, but it is unclear how the intracellular levels of these viral proteins are regulated after infection. Here we report that HIV-1 Rev causes specific degradation of cytoplasmic Tat, which results in inhibition of HIV-1 replication. The nuclear export signal (NES) region of Rev is crucial for this activity but is not involved in direct interactions with Tat. Rev reduces the levels of ubiquitinated forms of Tat, which have previously been reported to be important for its transcriptional properties. Tat is stabilized in the presence of NAD(P)H:quinine oxidoreductase 1 (NQO1), and potent degradation of Tat is induced by dicoumarol, an NQO1 inhibitor. Furthermore, Rev causes specific reduction in the levels of endogenous NQO1. Thus, we propose that Rev is able to induce degradation of Tat indirectly by downregulating NQO1 levels. Our findings have implications in HIV-1 gene expression and latency.
引用
收藏
页数:12
相关论文
共 54 条
  • [1] PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE
    ADACHI, A
    GENDELMAN, HE
    KOENIG, S
    FOLKS, T
    WILLEY, R
    RABSON, A
    MARTIN, MA
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 284 - 291
  • [2] The Protein Level of PGC-1α, a Key Metabolic Regulator, Is Controlled by NADH-NQO1
    Adamovich, Yaarit
    Shlomai, Amir
    Tsvetkov, Peter
    Umansky, Kfir B.
    Reuven, Nina
    Estall, Jennifer L.
    Spiegelman, Bruce M.
    Shaul, Yosef
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (13) : 2603 - 2613
  • [3] 20S proteasomal degradation of ornithine decarboxylase is regulated by NQ01
    Asher, G
    Bercovich, Z
    Tsvetkov, P
    Shaul, Y
    Kahana, C
    [J]. MOLECULAR CELL, 2005, 17 (05) : 645 - 655
  • [4] A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73
    Asher, G
    Tsvetkov, P
    Kahana, C
    Shaul, Y
    [J]. GENES & DEVELOPMENT, 2005, 19 (03) : 316 - 321
  • [5] 20S proteasomes and protein degradation "by default"
    Asher, Gad
    Reuven, Nina
    Shaul, Yosef
    [J]. BIOESSAYS, 2006, 28 (08) : 844 - 849
  • [6] Proteasomes Can Degrade a Significant Proportion of Cellular Proteins Independent of Ubiquitination
    Baugh, James M.
    Viktorova, Ekaterina G.
    Pilipenko, Evgeny V.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2009, 386 (03) : 814 - 827
  • [7] A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter
    Brès, V
    Kiernan, RE
    Linares, LK
    Chable-Bessia, C
    Plechakova, O
    Tréand, C
    Emiliani, S
    Peloponese, JM
    Jeang, KT
    Coux, O
    Scheffner, M
    Benkirane, M
    [J]. NATURE CELL BIOLOGY, 2003, 5 (08) : 754 - 761
  • [8] Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system
    Chang, LJ
    Urlacher, V
    Iwakuma, T
    Cui, Y
    Zucali, J
    [J]. GENE THERAPY, 1999, 6 (05) : 715 - 728
  • [9] Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
    Ciechanover, A
    [J]. CELL DEATH AND DIFFERENTIATION, 2005, 12 (09) : 1178 - 1190
  • [10] The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II
    Cujec, TP
    Okamoto, H
    Fujinaga, K
    Meyer, J
    Chamberlin, H
    Morgan, DO
    Peterlin, BM
    [J]. GENES & DEVELOPMENT, 1997, 11 (20) : 2645 - 2657